Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTERPARFUMS INCIPAR · Entity 4092 | Director | January 22, 2026 | January 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTERPARFUMS INC
Report date January 22, 2026 · Filed January 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,050 |
Reported balance
After 2026-01-22 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2026-01-22 · Exercise / conversion · Acquired 1,500 · Balance 3,050 |
| Common StockSEC Table I · non-derivative | Direct | 1,550 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,550 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $62.18 · Expires 2026-01-31 | Direct | 0 |
Reported balance
After 2026-01-22 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-01-22 · Exercise / conversion · Disposed 375 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $62.18 · Expires 2026-01-31 | Direct | 0 |
Reported balance
After 2026-01-22 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-01-22 · Exercise / conversion · Disposed 375 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $62.18 · Expires 2026-01-31 | Direct | 0 |
Reported balance
After 2026-01-22 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-01-22 · Exercise / conversion · Disposed 375 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $62.18 · Expires 2026-01-31 | Direct | 0 |
Reported balance
After 2026-01-22 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-01-22 · Exercise / conversion · Disposed 375 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 24
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 24 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 25
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 25 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-22 · row 26
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 26 · Balance 300 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2021 Filed Feb 3, 2021 21:23 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $62.18 | $0.00 |
DisclosureSEC source: 0001213900-21-006442 · ownership.xml · derivative · entry 13 Harrison Gilbert · CIK 0001734119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2026-01-31 Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 19:08 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-002542 · ownership.xml · derivative · entry 12 Harrison Gilbert · CIK 0001734119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2025-01-31 Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 19:08 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-002542 · ownership.xml · derivative · entry 11 Harrison Gilbert · CIK 0001734119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2025-01-31 Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 19:08 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-002542 · ownership.xml · derivative · entry 10 Harrison Gilbert · CIK 0001734119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2025-01-31 Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 19:08 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-002542 · ownership.xml · derivative · entry 9 Harrison Gilbert · CIK 0001734119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2025-01-31 Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 22:15 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $66.46 | $0.00 |
DisclosureSEC source: 0001615774-19-001854 · s115875_form4.xml · derivative · entry 8 Harrison Gilbert · CIK 0001734119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2024-01-31 Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 22:15 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $66.46 | $0.00 |
DisclosureSEC source: 0001615774-19-001854 · s115875_form4.xml · derivative · entry 7 Harrison Gilbert · CIK 0001734119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2024-01-31 Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 22:15 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $66.46 | $0.00 |
DisclosureSEC source: 0001615774-19-001854 · s115875_form4.xml · derivative · entry 6 Harrison Gilbert · CIK 0001734119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2024-01-31 Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 22:15 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $66.46 | $0.00 |
DisclosureSEC source: 0001615774-19-001854 · s115875_form4.xml · derivative · entry 5 Harrison Gilbert · CIK 0001734119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2024-01-31 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.